Study On Risk Assessment And Control Of Jiang Zhong Pharmaceutical Co.LTD

Along with the development of the trend of population aging,the pharmaceutical enterprises in our country for a better development opportunity,pharmaceutical manufacturing is about one of the important industry of national economy,compared with the pharmaceutical manufacturing industry of developed countries,China's pharmaceutical manufacturing industry on the lack of technical innovation,combined with domestic pharmaceutical enterprise scale is small,pharmaceutical manufacturing industry of China,there are a greater risk of developing.The risk assessment of the pharmaceutical manufacturing industry is conducive to improving the existing risk assessment theory system of the pharmaceutical industry,helping enterprise managers and investors to clarify the risks in the biological pharmaceutical industry through empirical research,and helping enterprise managers and investors to avoid risks reasonably.Whether in terms of research and development capacity,production efficiency or marketing methods,there is still a large space in the domestic pharmaceutical market,and it is difficult to predict the risks in the investment process.Therefore,the evaluation of investment risk of pharmaceutical enterprises is of great significance.This paper takes jiangzhong pharmaceutical co.,ltd.as the case of risk assessment and control,and studies and analyzes its risk assessment and control problems by combining quantitative and qualitative analysis methods.Firstly,the research background and significance,as well as the domestic and foreign research review are introduced in detail.Secondly,qualitative and quantitative analysis is made on the risk factors affecting jiangzhong pharmaceutical,and a risk evaluation system is constructed for the policy risks,research and development risks and financial risks encountered by jiangzhong pharmaceutical.The main conclusions of the study are as follows: sub-module jiangzhong pharmaceutical has a big risk problem,but the comprehensive analysis of the operation of jiangzhong pharmaceutical is relatively stable,there is no bankruptcy trend,and it is even good for the future development.Finally,put forward the risk of jiangzhong pharmaceutical prevention and control measures.It is hoped that the research in this paper can provide reference and help for the investors and managers of jiangzhong pharmaceutical to prevent and control risks,promote the development of enterprises and promote the healthy development of China's pharmaceutical market.